CENTURY THERAPEUTICS: CNTY-813 IND SUBMISSION REMAINS ON TRACK FOR Q4 2026; INITIAL CLINICAL DATA ANTICIPATED IN SECOND HALF OF 2027 - SEC FILING

Reuters · 3d ago

Please log in to view news